MXCT
MaxCyte, Inc. · Healthcare
EVP, Global Sales, Marketing Thomas M. Ross sold $172K of MaxCyte, Inc.
Sold$171,616
$5.02Price
34,160Shares
−100%Stake
What MXCT did after the filing
- The stock from Mon, Apr 10 open, $4.99
- −17.8%
- S&P 500, same days
- +3.0%
Measured over 30 trading days, to the May 22 close.
Traded Wed, Apr 5. Filed Fri, Apr 7, 12:43 PM ET, during the session. Returns use the Apr 10 open and the May 22 close. Not investment advice.